Treatment of Neuromyelitis Optica with Mycophenolate Mofetil in Japanese Patients
Not Applicable
- Conditions
- euromyelitis Optica
- Registration Number
- JPRN-UMIN000031135
- Lead Sponsor
- Kobe University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 9
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients with infection 2. Patients with pregnancy or breast-feeding 3. Patients who take any immunosuppressant other than steroid 4. patients with severe liver or kidney dysfunction 5. patients with a history of cancer within 5 years 6. In addition, patients judged inappropriate by the investigators
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assess the effect of Mycophenolate mofetil suppressing the recurrence of Neuromyelitis optics for 1 year
- Secondary Outcome Measures
Name Time Method